Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival "early on" in neoadjuvant treatment of breast cancer.
Kenny H ChaHui LiNatalia AntropovaAlexandra EdwardsJohn PapaioannouMaryellen L GigerPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2018)
The performance of the automatically-calculated METV rivaled that of a semi-manual model described for the ACRIN 6657 study (published C-statistic 0.72 [0.60; 0.84]), which involved the same dataset but required semi-manual delineation of the functional tumor volume (FTV) and knowledge of the pre-surgical residual cancer burden.